REPEAT THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99269503
- Mark type
- Stylized text
- Filed
- 07 Jul 2025
- Published for opposition
- 30 Dec 2025
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals; Providing a website featuring research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Providing a website featuring medical research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Pharmaceutical drug development services
Owner
- Repeat Therapeutics, Inc., La Jolla, CA, US
- Repeat Therapeutics, Inc., La Jolla, CA, US
Prosecution history
- 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Dec 2025 — PUBLISHED FOR OPPOSITION
- 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Nov 2025 — NON-FINAL ACTION E-MAILED
- 26 Nov 2025 — NON-FINAL ACTION WRITTEN
- 24 Nov 2025 — ASSIGNED TO EXAMINER
- 10 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Jul 2025 — NEW APPLICATION ENTERED